This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Questions about our CME?
Questions about our CME?
Managing Patients with Psoriasis and Comorbidities: Cases, Evidence and Action Plans

Managing Patients with Psoriasis and Comorbidities: Cases, Evidence and Action Plans

Format

Webcast

Time to Complete

1 hour

Released

April 30, 2018

Expires

April 30, 2019
Add to Queue


Maximum Credits

1.00 / AMA PRA Category 1 CreditTM
1.00 / CE for Nurses
1.00 / CE for Pharmacists (0.10 CEUs)

Accredited Provider


This educational initiative is provided by CME Outfitters.

Commercial Supporter

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

Program Description

Psoriasis is a common chronic inflammatory skin condition that affects 3% to 4% of adults in the United States. Genetic susceptibility, immune dysregulation, and environmental factors are all thought to play a role in the development of the condition. Immunopathogenic studies have revealed that tumor necrosis factor alpha (TNF-α) and interleukins (IL-12, IL-17, IL-22, IL-23) are key cytokines involved in the pathogenesis of psoriasis. In recent years, there has been a focus on the development of treatment agents targeting these inflammatory cytokines. Despite the availability of effective treatments for psoriasis, physicians often fail to recognize psoriasis as a systemic inflammatory disease, resulting in significant undertreatment. Specifically, moderate and severe psoriasis are often treated with topical agents rather than more potent biologic and oral treatments, contributing to suboptimal outcomes and poor patient satisfaction.

In this CME Outfitters webinar, participants will be presented with a real-world case scenario intermixed with nationally-known, expert faculty discussing the latest clinical data, guidelines, and quality measures and how they apply to the case as we add layers of complexity to our patient scenario. Finally, faculty will discuss creating personalized clinical action plans for patients with psoriasis and take questions during dedicated time for Q & A.

Intended Audience

Dermatologists, physician assistants, nurse practitioners, nurses, and pharmacists who treat patients with psoriasis

Educational Objectives

At the end of this CE activity, participants should be able to:

Physicians:

  • Describe the pathophysiologic pathways underlying psoriasis and the rationale for treatment selection based on the MOA of agents that target these pathways
  • Identify the comorbidities common in patients with psoriasis and the impact of these comorbidities on treatment selection
  • Select appropriate treatments for patients with psoriasis based on disease characteristics, and efficacy and safety profiles of treatments

CNE/CPE:

  • Describe the pathophysiologic pathways underlying psoriasis and the rationale for treatment selection based on the MOA of agents that target these pathways
  • Identify the comorbidities common in patients with psoriasis and the impact of these comorbidities on treatment selection
  • Describe appropriate treatments for patients with psoriasis based on disease characteristics, and efficacy and safety profiles of treatment

Conflict Of Interest Disclosure Policy

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Faculty

Joel M. Gelfand, MD, MSCE
Professor of Dermatology
Professor of Epidemiology
Vice Chair of Clinical Research and Medical Director
Dermatology Clinical Studies Unit
Director, Psoriasis and Phototherapy Treatment Center
University of Pennsylvania Perelman School of Medicine
Philadelphia, PA

Dr. Gelfand discloses the following:
Research Grants (to the Trustees of the University of Pennsylvania): AbbVie Inc.; Celgene Corporation; Janssen Biologics, Inc. Novartis Corporation; Pfizer Inc.; Regeneron Pharmaceuticals, Inc.; Sanofi
Consultant: Bristol-Myers Squibb Company; Coherus Biosciences; Dermira Inc.; Dr. Reddy’s Laboratories Ltd.; Janssen Biologics, Inc.; Menlo Therapeutics; Novartis Corporation; Pfizer Inc.; Sanofi; Regeneron Pharmaceuticals, Inc.
Other Financial or Material Support: Co-patent holder of resiquimod for treatment of cutaneous T cell lymphoma

Junko Takeshita, MD, PhD, MSCE
Assistant Professor of Dermatology
Assistant Professor of Epidemiology
University of Pennsylvania Perelman School of Medicine
Philadelphia, PA

Dr. Takeshita discloses the following:
Grants: Pfizer Inc.

Accredited Provider Disclosure

The CME Outfitters, LLC staff has nothing to disclose.

Planners' and Managers' Disclosures

Daniela V. DiBiase, MS (planning committee) has no disclosures to report.
Jan Perez (planning committee) has no disclosures to report.

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

CME Outfitters, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Designation Statement

CME Outfitters, LLC, designates this enduring material for a maximum of 1.00 AMA PRA Category 1 CreditTM  . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

1.00

Type

CE for Nurses

Accreditation Statement

CME Outfitters, LLC, is approved by the California Board of Registered Nursing.

Designation Statement

Provider approved by the California Board of Registered Nursing, Provider Number CEP 15510, for 1.00 contact hours

Credit

1.00

Type

CE for Pharmacists

Accreditation Statement

CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.00 contact hours (0.10 CEUs) Universal Activity Number:
0376-0000-18-002-H01-P
0376-0000-18-002-L01-P

Type: knowledge-based
practice-based

Additional Credit Information

Note to Nurse Practitioners: Nurse practitioners can apply for AMA PRA Category 1 CreditTM   through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 CreditTM   from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse practitioners can also apply for credit through their state boards.

Note to Physician Assistants: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM   from organizations accredited by the Accreditation Council for Continuing Medical Education.

Disclosure of Unlabeled Use

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Instructions

There are no fees for participating in this CME/CE activity. To receive credit, participants must (1) read the learning objectives and disclosure statements, (2) study the educational activity, and (3) complete the post-test and activity evaluation form, including the certificate information section.

To obtain a certificate, participants must receive a score of 75% or better on the post-test. The post-test can be accessed at the end of the activity. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

If you have any questions relating to the accreditation of this activity, please contact CME Outfitters at 877-263-7767.

If you have any other questions relating to your certificate or other issues with this activity, please contact myCME.Support@haymarketmedical.com.

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue